Related references
Note: Only part of the references are listed.Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Yin Wu et al.
SEMINARS IN CANCER BIOLOGY (2022)
Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy
Peng Bai et al.
ONCOIMMUNOLOGY (2021)
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy
Ithar Gataa et al.
EUROPEAN JOURNAL OF CANCER (2021)
The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival
Elise F. Nassif et al.
CANCERS (2021)
Precision immunity: Immunoscore and neoadjuvant treatment in bladder cancer
Elise F. Nassif et al.
ONCOIMMUNOLOGY (2021)
The Immunoscore: Colon Cancer and Beyond
Helen K. Angell et al.
CLINICAL CANCER RESEARCH (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
Anthony C. Antonelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer
Sujit S. Nair et al.
UROLOGIC CLINICS OF NORTH AMERICA (2020)
The prognostic value of Immunoscore in patients with cancer: A pooled analysis of 10,328 patients
Xingxia Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2020)
Importance of the immune system in head and neck cancer
Adal H. Mirza et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy
Xiang-Dong Li et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
Andrew R. H. Shepherd et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer
T. Horn et al.
WORLD JOURNAL OF UROLOGY (2016)
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence
Alessia Parodi et al.
ONCOTARGET (2016)
CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
Marian S. Wettstein et al.
DISEASE MARKERS (2015)
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer
Cedric Poyet et al.
ONCOLOGY LETTERS (2015)
Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
Cedric Poyet et al.
BMC CLINICAL PATHOLOGY (2014)
Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
E. Xylinas et al.
BRITISH JOURNAL OF CANCER (2013)
The association between the recurrence of solitary nonmuscle invasive bladder cancer and tumor infiltrating lymphocytes
Kristian Krpina et al.
CROATIAN MEDICAL JOURNAL (2012)
Cancer classification using the Immunoscore: a worldwide task force
Jerome Galon et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
FOXP3 and survival in urinary bladder cancer
Malin E. Winerdal et al.
BJU INTERNATIONAL (2011)
Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: Indications and efficacy of a differentiated approach
Michael Schulze et al.
JOURNAL OF ENDOUROLOGY (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines
Angelica Loskog et al.
JOURNAL OF UROLOGY (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Z Kirkali et al.
UROLOGY (2005)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Share Paper
